GB0414885D0 - Cancer therapy - Google Patents

Cancer therapy

Info

Publication number
GB0414885D0
GB0414885D0 GB0414885A GB0414885A GB0414885D0 GB 0414885 D0 GB0414885 D0 GB 0414885D0 GB 0414885 A GB0414885 A GB 0414885A GB 0414885 A GB0414885 A GB 0414885A GB 0414885 D0 GB0414885 D0 GB 0414885D0
Authority
GB
United Kingdom
Prior art keywords
cancer therapy
cancer
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0414885A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neutec Pharma Ltd
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Priority to GB0414885A priority Critical patent/GB0414885D0/en
Publication of GB0414885D0 publication Critical patent/GB0414885D0/en
Priority to JP2007518687A priority patent/JP2008504355A/en
Priority to MX2007000263A priority patent/MX2007000263A/en
Priority to SG200904521-2A priority patent/SG153877A1/en
Priority to CA002572318A priority patent/CA2572318A1/en
Priority to NZ552508A priority patent/NZ552508A/en
Priority to PCT/GB2005/002545 priority patent/WO2006003384A1/en
Priority to BRPI0512889-7A priority patent/BRPI0512889A/en
Priority to ZA200700845A priority patent/ZA200700845B/en
Priority to CNA2005800292973A priority patent/CN101010100A/en
Priority to US11/630,936 priority patent/US20080038267A1/en
Priority to RU2007104053/15A priority patent/RU2389507C2/en
Priority to AU2005259002A priority patent/AU2005259002B2/en
Priority to KR1020077002582A priority patent/KR20070050918A/en
Priority to EP05756172A priority patent/EP1763366A1/en
Priority to MA29587A priority patent/MA28701B1/en
Priority to TNP2006000454A priority patent/TNSN06454A1/en
Priority to IL180460A priority patent/IL180460A/en
Priority to NO20070580A priority patent/NO20070580L/en
Priority to ECSP077219 priority patent/ECSP077219A/en
Ceased legal-status Critical Current

Links

GB0414885A 2004-07-02 2004-07-02 Cancer therapy Ceased GB0414885D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0414885A GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy
EP05756172A EP1763366A1 (en) 2004-07-02 2005-06-30 Treatment of cancer
ZA200700845A ZA200700845B (en) 2004-07-02 2005-06-30 Treatment of cancer
US11/630,936 US20080038267A1 (en) 2004-07-02 2005-06-30 Treatment Of Cancer
SG200904521-2A SG153877A1 (en) 2004-07-02 2005-06-30 Treatment of cancer
CA002572318A CA2572318A1 (en) 2004-07-02 2005-06-30 Treatment of cancer
NZ552508A NZ552508A (en) 2004-07-02 2005-06-30 Treatment of cancer with pharmaceutical agents together with anti-Hsp 90 antibodies
PCT/GB2005/002545 WO2006003384A1 (en) 2004-07-02 2005-06-30 Treatment of cancer
BRPI0512889-7A BRPI0512889A (en) 2004-07-02 2005-06-30 use of an antibody or antigen binding fragment thereof and at least one anticancer agent, combined preparation, and methods of treating cancer and leukemia
JP2007518687A JP2008504355A (en) 2004-07-02 2005-06-30 Cancer treatment
CNA2005800292973A CN101010100A (en) 2004-07-02 2005-06-30 Treatment of cancer
MX2007000263A MX2007000263A (en) 2004-07-02 2005-06-30 Treatment of cancer.
RU2007104053/15A RU2389507C2 (en) 2004-07-02 2005-06-30 Cancer treatment
AU2005259002A AU2005259002B2 (en) 2004-07-02 2005-06-30 Treatment of cancer
KR1020077002582A KR20070050918A (en) 2004-07-02 2005-06-30 Treatment of cancer
TNP2006000454A TNSN06454A1 (en) 2004-07-02 2006-12-29 Treatment of cancer
MA29587A MA28701B1 (en) 2004-07-02 2006-12-29 TREATMENT OF CANCER
IL180460A IL180460A (en) 2004-07-02 2006-12-31 COMBINED PREPARATION FOR TREATING CANCER COMPRISING AN ANTI-Hsp90 ANTIBODY AND AT LEAST ONE ANTI-CANCER AGENT
NO20070580A NO20070580L (en) 2004-07-02 2007-01-31 Treatment of cancer.
ECSP077219 ECSP077219A (en) 2004-07-02 2007-02-02 CANCER TREATMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0414885A GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy

Publications (1)

Publication Number Publication Date
GB0414885D0 true GB0414885D0 (en) 2004-08-04

Family

ID=32843486

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0414885A Ceased GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy

Country Status (3)

Country Link
GB (1) GB0414885D0 (en)
TN (1) TNSN06454A1 (en)
ZA (1) ZA200700845B (en)

Also Published As

Publication number Publication date
ZA200700845B (en) 2008-09-25
TNSN06454A1 (en) 2008-02-22

Similar Documents

Publication Publication Date Title
EP1814544A4 (en) Cancer treatments
IL186662A0 (en) Combination cancer therapy with
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
EP1830847A4 (en) Treatment for cancer
IL177155A0 (en) Therapeutic combinations
GB0504206D0 (en) Combination therapy
GB0509052D0 (en) Combination therapy
GB0417481D0 (en) Combination therapy
GB0428180D0 (en) Combination therapy
GB0428187D0 (en) Cancer treatment
GB0424339D0 (en) Combination therapy
GB0413346D0 (en) Treating cancer
GB0417558D0 (en) Novel combination therapy
GB0404675D0 (en) Cancer treatment
GB0507685D0 (en) Cancer treatment
GB0414885D0 (en) Cancer therapy
GB0410379D0 (en) Treatment of cancer
GB0423273D0 (en) Treatment of cancer
GB0421436D0 (en) Combination therapy
GB0421438D0 (en) Combination therapy
GB0406546D0 (en) Combination therapy
GB0407755D0 (en) Combination therapy
GB0407753D0 (en) Combination therapy
GB0424638D0 (en) Combination therapy
GB0406450D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)